Identifying clustering in patterns of late effects among survivors of adolescent and young adult hodgkin lymphoma.

IF 4.1 Q2 ONCOLOGY
Kellee Parker, Mallorie Heneghan, Qian W Li, Ann Brunson, Judy Ou, Heydon K Kaddas, Renata Abrahão, Jessica Chubak, Karen J Wernli, Brad Zebrack, Erin E Hahn, Lawrence H Kushi, Hazel B Nichols, Theresa Keegan, Anne C Kirchhoff
{"title":"Identifying clustering in patterns of late effects among survivors of adolescent and young adult hodgkin lymphoma.","authors":"Kellee Parker, Mallorie Heneghan, Qian W Li, Ann Brunson, Judy Ou, Heydon K Kaddas, Renata Abrahão, Jessica Chubak, Karen J Wernli, Brad Zebrack, Erin E Hahn, Lawrence H Kushi, Hazel B Nichols, Theresa Keegan, Anne C Kirchhoff","doi":"10.1093/jncics/pkaf094","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We examined late effects clustering among adolescent and young adult (AYA; age 15-39 years at diagnosis) Hodgkin Lymphoma (HL) survivors and identified characteristics associated with each cluster.</p><p><strong>Methods: </strong>We included AYAs with HL in 2006-2018 from the California and Utah Cancer Registries linked to statewide hospitalization, emergency department, and ambulatory surgery visit data. We identified severe late effects >2 years after cancer diagnosis in nine late effects categories. Latent class analysis (LCA) was used to identify late effects clusters. Multinomial logistic regression models estimated adjusted associations of demographic and treatment characteristics with LCA late effect group.</p><p><strong>Results: </strong>We identified 4,635 AYA HL survivors with median follow-up of 8.2 years and four late effects groups: 77.1% had a low probability of any late effect (Low Morbidity), 12.8% had high probability of Thyroid disorders, 8.0% had high probability of Cardiovascular Disease (CVD), and 2.1% had high probability of Multiple Conditions (CVD, diabetes/pancreatic, thyroid, and renal diseases). Publicly insured AYAs were more likely than those with private insurance to be in the CVD (OR = 1.53, 95%CI = 1.18-1.98) and Multiple Conditions (OR = 2.17, 95%CI = 1.29-3.66) than the Low Morbidity group. AYAs with radiation were more likely to be in the Multiple Conditions (OR = 2.31, 95%CI = 1.41-3.78) and Thyroid (OR = 2.81, 95%CI = 2.20-3.58) groups. Hematopoietic cell transplantation was associated with Multiple Conditions (OR = 9.50, 95%CI = 5.82-15.50), CVD (OR = 3.82, 95%CI = 2.96-4.93), and Thyroid (OR = 2.86, 95%CI = 2.12-3.85) groups.</p><p><strong>Conclusions: </strong>While most AYA HL survivors were in the Low Morbidity group, those with public insurance or intense treatment may be at higher risk for multiple conditions.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkaf094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We examined late effects clustering among adolescent and young adult (AYA; age 15-39 years at diagnosis) Hodgkin Lymphoma (HL) survivors and identified characteristics associated with each cluster.

Methods: We included AYAs with HL in 2006-2018 from the California and Utah Cancer Registries linked to statewide hospitalization, emergency department, and ambulatory surgery visit data. We identified severe late effects >2 years after cancer diagnosis in nine late effects categories. Latent class analysis (LCA) was used to identify late effects clusters. Multinomial logistic regression models estimated adjusted associations of demographic and treatment characteristics with LCA late effect group.

Results: We identified 4,635 AYA HL survivors with median follow-up of 8.2 years and four late effects groups: 77.1% had a low probability of any late effect (Low Morbidity), 12.8% had high probability of Thyroid disorders, 8.0% had high probability of Cardiovascular Disease (CVD), and 2.1% had high probability of Multiple Conditions (CVD, diabetes/pancreatic, thyroid, and renal diseases). Publicly insured AYAs were more likely than those with private insurance to be in the CVD (OR = 1.53, 95%CI = 1.18-1.98) and Multiple Conditions (OR = 2.17, 95%CI = 1.29-3.66) than the Low Morbidity group. AYAs with radiation were more likely to be in the Multiple Conditions (OR = 2.31, 95%CI = 1.41-3.78) and Thyroid (OR = 2.81, 95%CI = 2.20-3.58) groups. Hematopoietic cell transplantation was associated with Multiple Conditions (OR = 9.50, 95%CI = 5.82-15.50), CVD (OR = 3.82, 95%CI = 2.96-4.93), and Thyroid (OR = 2.86, 95%CI = 2.12-3.85) groups.

Conclusions: While most AYA HL survivors were in the Low Morbidity group, those with public insurance or intense treatment may be at higher risk for multiple conditions.

识别聚类在青少年和青年霍奇金淋巴瘤幸存者的晚期影响模式。
背景:我们研究了青少年和年轻成人(AYA;诊断时年龄15-39岁)霍奇金淋巴瘤(HL)幸存者的晚期效应聚类,并确定了每个聚类的相关特征。方法:我们纳入了2006-2018年加利福尼亚州和犹他州癌症登记处与全州住院、急诊科和门诊手术就诊数据相关的HL患者。我们在癌症诊断后2年内确定了9个晚期影响类别的严重晚期影响。潜在类分析(LCA)用于识别晚期效应聚类。多项逻辑回归模型估计了LCA晚期效应组的人口统计学和治疗特征的调整相关性。结果:我们确定了4,635名AYA HL幸存者,中位随访时间为8.2年,分为4个晚期效应组:77.1%的晚期效应发生率低(低发病率),12.8%的甲状腺疾病发生率高,8.0%的心血管疾病(CVD)发生率高,2.1%的多重疾病发生率高(CVD、糖尿病/胰腺、甲状腺和肾脏疾病)。与低发病率组相比,公共保险的青少年比私人保险的青少年更有可能患有心血管疾病(OR = 1.53, 95%CI = 1.18-1.98)和多种疾病(OR = 2.17, 95%CI = 1.29-3.66)。合并放疗的aya多发生在多条件组(OR = 2.31, 95%CI = 1.41 ~ 3.78)和甲状腺组(OR = 2.81, 95%CI = 2.20 ~ 3.58)。造血细胞移植与多种疾病(OR = 9.50, 95%CI = 5.82-15.50)、心血管疾病(OR = 3.82, 95%CI = 2.96-4.93)和甲状腺(OR = 2.86, 95%CI = 2.12-3.85)组相关。结论:虽然大多数AYA HL幸存者属于低发病率组,但那些有公共保险或强化治疗的患者可能有更高的多种疾病风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信